Corwave
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | - | - | - | 7.7m | - |
| EBITDA | (1.4m) | (2.0m) | (4.1m) | (<1m) | (<1m) | (<1m) | (1.4m) |
| % EBITDA margin | - | - | - | - | - | (12 %) | - |
| Profit | (1.3m) | (1.6m) | (3.9m) | (<1m) | (<1m) | (<1m) | (<1m) |
| % profit margin | - | - | - | - | - | (3 %) | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Support Program | |
€680k | Seed | ||
| N/A | €3.3m | Series A | |
€3.5m | Series A | ||
€1.5m | Grant | ||
€15.6m | Series B | ||
* | N/A | $16.5m | Series C |
€1.9m | Grant | ||
€2.5m | Grant | ||
€35.0m Valuation: €78.0m 10.1x EV/LTM Revenues -84.6x EV/LTM EBITDA | Series C | ||
* | €26.0m Valuation: €175m | Series C | |
| Total Funding | €105m | ||
Related Content
Recent News about Corwave
EditDeveloper of innovative implanted cardiac support devices designed to help patients suffering from heart failure. The company's devices consist of an implantable heart pump based on wave membrane pumping technology and use an oscillating membrane to displace fluid, enabling patients to lessen the suffering from complications and reduce the pain and burden from invasive surgery.
Keywords: Healthcare Devices / Services / Supplies, Technology Hardware, Blood Pump Technology, Cardiac Assisting, Cardiac Support Device, Heart Failure Therapy, Pulsatile Blood Flow, Tubular Membrane Filter, Undulating Membrane, Ventricular Assisting Device.